Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07099989 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics of Zelquistinel in Fasted or Fed State
A Phase 1 study of Healthy Volunteers in Fed and Fasted State, sponsored by Syndeio Biosciences.
- Active
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT07099989: Active Phase 1 study of Healthy Volunteers in Fed and Fasted State, sponsored by Syndeio Biosciences.
NCT07099989 is a Phase 1 study of Healthy Volunteers in Fed and Fasted State that is active but no longer recruiting, run by Syndeio Biosciences. The registered enrollment target is 32 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07099989, a Phase 1 study of Healthy Volunteers in Fed and Fasted State, is active but no longer recruiting, sponsored by Syndeio Biosciences.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this study is to assess the effect of food on the rate and extent of absorption of a single dose of Zelquistinel 3 mg or 10 mg oral tablets tablets in healthy adult volunteers.
Primary Outcome
Maximum concentration in plasma
Conditions Studied
Interventions
- DRUG Zelquistinel 3 mg
- DRUG Zelquistinel 10 mg
Study Locations (1)
Kansas
- Dr. Vince Clinical Research - Overland Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2025-07-24 |
| Est. Completion | 2026-07 |
| Phase | Phase 1 |
What the registry record for NCT07099989 still lists
NCT07099989 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% lower).
The record links to 1 condition, with Healthy Volunteers in Fed and Fasted State appearing as the primary indexed condition, and to 2 interventions - of which Zelquistinel 3 mg is the first listed.
NCT07099989 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT07099989 about?
NCT07099989 is a clinical study titled "Pharmacokinetics of Zelquistinel in Fasted or Fed State". The primary purpose of this study is to assess the effect of food on the rate and extent of absorption of a single dose of Zelquistinel 3 mg or 10 mg oral tablets tablets in healthy adult volunteers.
What is the current status of trial NCT07099989?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2025-07-24. Estimated completion is 2026-07.
What conditions does trial NCT07099989 study?
This clinical trial studies the following conditions: Healthy Volunteers in Fed and Fasted State.
What interventions are being tested in trial NCT07099989?
The interventions under investigation include: Zelquistinel 3 mg (DRUG), Zelquistinel 10 mg (DRUG).
Who is sponsoring clinical trial NCT07099989?
This trial is sponsored by Syndeio Biosciences, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07099989 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07099989's enrollment target sits among peer trials
32 1296th of 2000 higher than 679 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI